BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23233746)

  • 1. The quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventions.
    Ardati AK; Kaufman SR; Aronow HD; Nypaver TJ; Bove PG; Gurm HS; Grossman PM
    Circ Cardiovasc Interv; 2012 Dec; 5(6):850-5. PubMed ID: 23233746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal medical management before lower extremity bypass for claudication in the veteran population.
    Williams CR; Jellison A; Martin L; Zhang C; Presson AP; Kraiss LW; Brooke BS
    J Vasc Surg; 2019 Feb; 69(2):545-554. PubMed ID: 30108008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
    Armstrong EJ; Chen DC; Westin GG; Singh S; McCoach CE; Bang H; Yeo KK; Anderson D; Amsterdam EA; Laird JR
    J Am Heart Assoc; 2014 Apr; 3(2):e000697. PubMed ID: 24721799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease.
    Lo RC; Bensley RP; Dahlberg SE; Matyal R; Hamdan AD; Wyers M; Chaikof EL; Schermerhorn ML
    J Vasc Surg; 2014 Feb; 59(2):409-418.e3. PubMed ID: 24080134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.
    Klingelhoefer E; Bergert H; Kersting S; Ludwig S; Weiss N; Schönleben F; Grützmann R; Gäbel G
    J Vasc Surg; 2016 Aug; 64(2):380-388.e1. PubMed ID: 27763266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).
    Kiesz RS; Wiernek SL; Wiernek BK; Radvany MG; Buszman PP; Szymanski R; Konkolewska MD; Martin JL; Buszman PE
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E244-50. PubMed ID: 23172729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry.
    Stavroulakis K; Borowski M; Torsello G; Bisdas T;
    J Vasc Surg; 2017 Nov; 66(5):1534-1542. PubMed ID: 28807382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.
    Bodewes TCF; Ultee KHJ; Soden PA; Zettervall SL; Shean KE; Jones DW; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 May; 65(5):1354-1365.e2. PubMed ID: 28190717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry.
    Plaisance BR; Munir K; Share DA; Mansour MA; Fox JM; Bove PG; Riba AL; Chetcuti SJ; Gurm HS; Grossman PM;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):694-701. PubMed ID: 21700256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for 30-day unplanned readmission following infrainguinal endovascular interventions.
    Bodewes TC; Soden PA; Ultee KH; Zettervall SL; Pothof AB; Deery SE; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 Feb; 65(2):484-494.e3. PubMed ID: 28126175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Natural History and Outcomes of Endovascular Therapy for Claudication.
    Saraidaridis JT; Ergul EA; Clouse WD; Patel VI; Cambria RP; Conrad MF
    Ann Vasc Surg; 2017 Oct; 44():34-40. PubMed ID: 28479467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underutilization of medical management of peripheral artery disease among patients with claudication undergoing lower extremity bypass.
    Howard R; Albright J; Powell C; Osborne N; Corriere M; Laveroni E; Sukul D; Goodney P; Henke P
    J Vasc Surg; 2022 Oct; 76(4):1037-1044.e2. PubMed ID: 35709853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editor's Choice - Dual Antiplatelet Therapy Improves Outcome in Diabetic Patients Undergoing Endovascular Femoropopliteal Stenting for Critical Limb Ischaemia.
    Thott O; Granath F; Malmstedt J; Wahlgren CM
    Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):403-410. PubMed ID: 28131536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revascularization of smokers with claudication is not predicted to limit quality of life despite a higher risk of late failure.
    Mixson JD; Brothers TE
    J Vasc Surg; 2017 Jan; 65(1):128-135.e1. PubMed ID: 27687324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease.
    Chen DC; Armstrong EJ; Singh GD; Amsterdam EA; Laird JR
    Vasc Health Risk Manag; 2015; 11():185-92. PubMed ID: 25767395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.
    Bertges DJ; White R; Cheng YC; Sun T; Ramkumar N; Goodney PP; Wilgus RW; Lottes AE; Smale JA; Drozda J; Raska M; Heise T; Jones WS; Tcheng JE; Eldrup-Jorgensen J; Sedrakyan A; Malone ML; Marinac-Dabic D; Thatcher R; Morales P; Krucoff MW; Cronenwett JL;
    J Vasc Surg; 2021 May; 73(5):1702-1714.e11. PubMed ID: 33080324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatments for peripheral artery disease.
    Bartholomew J; Bishop GJ
    Cleve Clin J Med; 2020 May; 87(5 suppl 1):21-25. PubMed ID: 32349971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use improves limb salvage after intervention for peripheral arterial disease.
    Parmar GM; Novak Z; Spangler E; Patterson M; Passman MA; Beck AW; Pearce BJ
    J Vasc Surg; 2019 Aug; 70(2):539-546. PubMed ID: 30718113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease.
    Armstrong EJ; Anderson DR; Yeo KK; Singh GD; Bang H; Amsterdam EA; Freischlag JA; Laird JR
    J Vasc Surg; 2015 Jul; 62(1):157-165.e1. PubMed ID: 25864042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.